Award

Delivery Order #SPE2D326F199Y

DLA Orders Provera Tablets from Pfizer Under Pharmaceutical Supply Contract

Buyer

Defense Logistics Agency

Award Amount

$195.95

Ceiling

$195.95

Awarded

June 17, 2026

Period of Performance

Jun 17, 2026 – Jun 18, 2026

Identifier

SPE2D326F199Y

NAICS

325412

This delivery order, issued under the Defense Logistics Agency’s long-term pharmaceutical supply agreement with Pfizer Inc., covers Provera (medroxyprogesterone acetate) 2.5 mg tablets in 100-count packaging. Pfizer is a pharmaceutical manufacturer supplying medicines for government and military needs. The order supports access to prescription medication through the agency’s established procurement program; the record does not specify the intended patients or further delivery requirements. The parent agreement was competitively awarded, but the record does not state the competition method for this individual order. The parent vehicle runs over a multi-year period, and this order has a brief performance window. No acquisition program, subcontractors, related prior orders, or original solicitation details are provided.

Description

4572166139!PROVERA 2.5 MG TABLET 100S

View original record